These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1188747)

  • 1. Proceedings: Structural abnormality in the gamma polypeptide chain of Paris I fibrinogen.
    Budzynski AZ; Marder VJ; Ménaché D; Guillin MC
    Thromb Diath Haemorrh; 1975 Sep; 34(1):329. PubMed ID: 1188747
    [No Abstract]   [Full Text] [Related]  

  • 2. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen].
    Soria J; Soria C
    Pathol Biol (Paris); 1974 Nov; 22 suppl():72-9. PubMed ID: 4620099
    [No Abstract]   [Full Text] [Related]  

  • 3. Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I).
    Budzynski AZ; Marder VJ; Ménaché D; Guillin MC
    Nature; 1974 Nov; 252(5478):66-8. PubMed ID: 4427684
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
    Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
    Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunoelectrophoretic study of fibrinogen and of degradation products of fibrinogen and fibrin].
    Karpinskaia VM
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):53-6. PubMed ID: 5736826
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Observations on fragment D species arising during hydrolysis of crosslinked human fibrin.
    Mosesson MW; Finlayson JS
    Thromb Diath Haemorrh; 1975 Sep; 34(1):328. PubMed ID: 127400
    [No Abstract]   [Full Text] [Related]  

  • 9. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
    Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassays for diagnosis of coagulation disorders.
    Kappel A; Ehm M
    Hamostaseologie; 2010 Nov; 30(4):194-201. PubMed ID: 21057714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and detection of fibrinogen derived complexes.
    Latallo ZS
    Thromb Diath Haemorrh; 1975 Dec; 34(3):677-85. PubMed ID: 1209540
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic of blood coagulation].
    Barthels M
    Hamostaseologie; 2008 Dec; 28(5):320-34. PubMed ID: 19132163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital abnormal fibrinogens.
    Ménaché D
    Prog Clin Biol Res; 1981; 72():205-20. PubMed ID: 7335649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Structural studies of fibrinogen by ultrasound irradiation.
    Albert A; Ayuso MR; Usobiaga P
    Thromb Diath Haemorrh; 1975 Nov; 34(2):573. PubMed ID: 1198466
    [No Abstract]   [Full Text] [Related]  

  • 16. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
    Siatkovskiĭ VA; Azarova LA; Vasilenko PL
    Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy.
    Colasanti G; Morel Maroger L; D'Amico G
    Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M; Baba M; Morimoto K; Nakamikawa C
    J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
    Anders O; Görss EW; Ernst B; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.